Alaska Permanent Fund Invests in Cancer Research Startup
Posted on 12/09/2013
Did you know sovereign wealth funds invest in cancer research? On December 4th, Seattle-based Juno Therapeutics Inc., a biotechnology startup focused on cancer therapeutics, launched with US$ 120 million in series A funding. It was one of the biggest Series A rounds for biotechnology startups on record. The capital comes from investors including ARCH Venture […]
- Alaska Permanent Fund Corporation
- Alternatives
- ARCH Venture Partners
- Crestline Investors
- Juno Therapeutics
- Series A
- Venture Capital
- Warburg Pincus
